- Home
- PLTK vs BHVN Comparison
PLTK vs BHVN Comparison
Compare PLTK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- BHVN
- Stock Information
- Founded
- PLTK 2010
- BHVN 2013
- Country
- PLTK Israel
- BHVN United States
- Employees
- PLTK N/A
- BHVN N/A
- Industry
- PLTK EDP Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- PLTK Technology
- BHVN Health Care
- Exchange
- PLTK Nasdaq
- BHVN Nasdaq
- Market Cap
- PLTK 2.0B
- BHVN 1.9B
- IPO Year
- PLTK 2021
- BHVN 2017
- Fundamental
- Price
- PLTK $4.74
- BHVN $15.13
- Analyst Decision
- PLTK Buy
- BHVN Strong Buy
- Analyst Count
- PLTK 7
- BHVN 14
- Target Price
- PLTK $7.68
- BHVN $59.85
- AVG Volume (30 Days)
- PLTK 1.8M
- BHVN 2.4M
- Earning Date
- PLTK 05-08-2025
- BHVN 05-12-2025
- Dividend Yield
- PLTK 8.45%
- BHVN N/A
- EPS Growth
- PLTK N/A
- BHVN N/A
- EPS
- PLTK 0.37
- BHVN N/A
- Revenue
- PLTK $2,604,100,000.00
- BHVN N/A
- Revenue This Year
- PLTK $13.29
- BHVN N/A
- Revenue Next Year
- PLTK $3.74
- BHVN $65.26
- P/E Ratio
- PLTK $12.65
- BHVN N/A
- Revenue Growth
- PLTK 1.64
- BHVN N/A
- 52 Week Low
- PLTK $3.97
- BHVN $14.33
- 52 Week High
- PLTK $9.07
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- PLTK 44.13
- BHVN 31.09
- Support Level
- PLTK $4.49
- BHVN $14.86
- Resistance Level
- PLTK $4.93
- BHVN $15.94
- Average True Range (ATR)
- PLTK 0.17
- BHVN 1.27
- MACD
- PLTK -0.02
- BHVN -0.16
- Stochastic Oscillator
- PLTK 29.82
- BHVN 3.31
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.